Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Capital Expenditures (2016 - 2025)

Harte Hanks (HHS) has disclosed Capital Expenditures for 16 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures rose 579.73% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 61.39% increase, with the full-year FY2024 number at $3.7 million, up 33.21% from a year prior.
  • Capital Expenditures was $1.0 million for Q3 2025 at Harte Hanks, up from $223000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $3.4 million in Q4 2022 to a low of -$429000.0 in Q2 2022.
  • A 5-year average of $880947.4 and a median of $679000.0 in 2023 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 1061.56% in 2022; the steepest drop was 173.08% in 2022.
  • Harte Hanks' Capital Expenditures stood at $294000.0 in 2021, then skyrocketed by 1061.56% to $3.4 million in 2022, then plummeted by 74.32% to $877000.0 in 2023, then skyrocketed by 167.27% to $2.3 million in 2024, then tumbled by 57.08% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Capital Expenditures are $1.0 million (Q3 2025), $223000.0 (Q2 2025), and $105000.0 (Q1 2025).